Giuseppe Palladino

Translational Science Lead-respiratory & Immunology @AstraZeneca

Cambridge, GB

Lead the development and the execution of the Translational Biomarker Strategy for new targets and First-In-Human (FIH) studies up to Phase 3 clinical studies by integrating technology experts, collaborating with other functions within a matrix team and utilizing public and proprietary datasets to enable human target validation, target engagement and precision medicine strategies in Immunology and Respiratory.• Enable Clinical study setup and study’s first subject in (FSI) by contributing to the authoring of the relevant clinic study and project specific documentation. • Enable drug’s Life Cycle Management (LCM) by leading the Translational Science activities to provide evinces for the use of the drug in a different patients subgroups or indications.

Università degli Studi del Sannio-Benevento

Master's degree, Biological Sciences

Università degli Studi di Foggia

Doctor of Philosophy - PhD, Experimental and Clinical Oncology